Activation of transmembrane cell-surface receptors via a common mechanism? The "rotation model"

BioEssays

Volumn 37, Issue 9, 2015, Pages 959-967

  Maruyama, Ichiro N ^a  

^a OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY GRADUATE UNIVERSITY   (Japan)

Author keywords

Cytokine; Dimerization; Ligand binding; Preformed dimer; Transmembrane signaling; Tyrosine kinase

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE RECEPTOR; EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GROWTH HORMONE RECEPTOR; HOMODIMER; INTERLEUKIN 12; INTERLEUKIN 6; LEPTIN RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; PROLACTIN RECEPTOR; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; VASCULOTROPIN RECEPTOR 2; LIGAND;

ALKALINITY; AUTOPHOSPHORYLATION; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL GROWTH; CELL MIGRATION; CELL SURFACE; CELL SURVIVAL; CHEMICAL STRUCTURE; CONFORMATION; CROSS LINKING; DIFFERENTIATION; DIMERIZATION; DISULFIDE BOND; EMBRYO DEVELOPMENT; ENZYME CONFORMATION; LIGAND BINDING; MOLECULAR DYNAMICS; NOTE; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL MEMBRANE; HUMAN; METABOLISM; PROTEIN MULTIMERIZATION; ROTATION;

ANIMALS; CELL MEMBRANE; HUMANS; LIGANDS; MODELS, BIOLOGICAL; PROTEIN MULTIMERIZATION; RECEPTORS, CELL SURFACE; ROTATION;

EID: 84939653139     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201500041     Document Type: Note

References (102)

1. Yarden Y, Schlessinger J. 1987. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 26: 1443-51.
2. Boni-Schnetzler M, Pilch PF. 1987. Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci USA 84: 7832-6.
3. Cochet C, Kashles O, Chambaz EM, Borrello I, et al. 1988. Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J Biol Chem 263: 3290-5.
4. Endres NF, Barros T, Cantor AJ, Kuriyan J. 2014. Emerging concepts in the regulation of the EGF receptor and other receptor tyrosine kinases. Trends Biochem Sci 39: 437-46.
5. Lemmon MA, Schlessinger J, Ferguson KM. 2014. The EGFR family: not so prototypical receptor tyrosine kinases. Cold Spring Harb Perspect Biol 6: a020768.
6. De Meyts P. 2015. Insulin/receptor binding: the last piece of the puzzle? BioEssays 37: 389-97.
7. Ward CW, Menting JG, Lawrence MC. 2013. The insulin receptor changes conformation in unforeseen ways on ligand binding: sharpening the picture of insulin receptor activation. BioEssays 35: 945-54.
8. Blume-Jensen P, Hunter T. 2001. Oncogenic kinase signaling. Nature 411: 355-65.
9. Maruyama IN. 2014. Mechanisms of activation of receptor tyrosine kinases: monomers or dimers. Cells 3: 304-30.
10. Moriki T, Maruyama H, Maruyama IN. 2001. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol 311: 1011-26.
11. Martin-Fernandez M, Clarke DT, Tobin MJ, Jones SV, et al. 2002. Preformed oligomeric epidermal growth factor receptors undergo an ectodomain structure change during signaling. Biophys J 82: 2415-27.
12. Clayton AH, Walker F, Orchard SG, Henderson C, et al. 2005. Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis. J Biol Chem 280: 30392-9.
13. Liu P, Sudhaharan T, Koh RM, Hwang LC, et al. 2007. Investigation of the dimerization of proteins from the epidermal growth factor receptor family by single wavelength fluorescence cross-correlation spectroscopy. Biophys J 93: 684-98.
14. Bader AN, Hofman EG, Voortman J, En Henegouwen PM, et al. 2009. Homo-FRET imaging enables quantification of protein cluster sizes with subcellular resolution. Biophys J 97: 2613-22.
15. Saffarian S, Li Y, Elson EL, Pike LJ. 2007. Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis. Biophys J 93: 1021-31.
16. Ma X, Ahmed S, Wohland T. 2011. EGFR activation monitored by SW-FCCS in live cells. Front Biosci (Elite Ed.) 3: 22-32.
17. Teramura Y, Ichinose J, Takagi H, Nishida K, et al. 2006. Single-molecule analysis of epidermal growth factor binding on the surface of living cells. EMBO J 25: 4215-22.
18. Tao RH, Maruyama IN. 2008. All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J Cell Sci 121: 3207-17.
19. Yang KS, Ilagan MX, Piwnica-Worms D, Pike LJ. 2009. Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor. J Biol Chem 284: 7474-82.
20. Macdonald-Obermann JL, Piwnica-Worms D, Pike LJ. 2012. Mechanics of EGF receptor/ErbB2 kinase activation revealed by luciferase fragment complementation imaging. Proc Natl Acad Sci USA 109: 137-42.
21. Macdonald-Obermann JL, Adak S, Landgraf R, Piwnica-Worms D, et al. 2013. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging. J Biol Chem 288: 30773-84.
22. Canals F. 1992. Signal transmission by epidermal growth factor receptor: coincidence of activation and dimerization. Biochemistry 31: 4493-501.
23. Cormack BP, Valdivia RH, Falkow S. 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173: 33-8.
24. Tsien RY. 1998. The green fluorescent protein. Annu Rev Biochem 67: 509-44.
25. Nagai T, Ibata K, Park ES, Kubota M, et al. 2002. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol 20: 87-90.
26. Lu C, Mi LZ, Grey MJ, Zhu J, et al. 2010. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol Cell Biol 30: 5432-43.
27. Burke CL, Stern DF. 1998. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface. Mol Cell Biol 18: 5371-9.
28. Shen J, Maruyama IN. 2011. Nerve growth factor receptor TrkA exists as a preformed, yet inactive, dimer in living cells. FEBS Lett 585: 295-9.
29. Shen J, Maruyama IN. 2012. Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells. J Mol Sign 7: 2.
30. Vilar M, Charalampopoulos I, Kenchappa RS, Simi A, et al. 2009. Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron 62: 72-83.
31. Deyev IE, Sohet F, Vassilenko KP, Serova OV, et al. 2011. Insulin receptor-related receptor as an extracellular alkali sensor. Cell Metab 13: 679-89.
32. Massague J, Pilch PF, Czech MP. 1980. Electrophoretic resolution of three major insulin receptor structures with unique subunit stoichiometries. Proc Natl Acad Sci USA 77: 7137-41.
33. Zhang B, Roth RA. 1992. The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities. J Biol Chem 267: 18320-8.
34. Moxham CP, Duronio V, Jacobs S. 1989. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers. J Biol Chem 264: 13238-44.
35. Soos MA, Siddle K. 1989. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. Biochem J 263: 553-63.
36. Bush JO, Soriano P. 2012. Eph/ephrin signaling: genetic, phosphoproteomic, and transcriptomic approaches. Semin Cell Dev Biol 23: 26-34.
37. Wimmer-Kleikamp SH, Janes PW, Squire A, Bastiaens PI, et al. 2004. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J Cell Biol 164: 661-6.
38. Seiradake E, Harlos K, Sutton G, Aricescu AR, et al. 2010. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat Struct Mol Biol 17: 398-402.
39. Himanen JP, Yermekbayeva L, Janes PW, Walker JR, et al. 2010. Architecture of Eph receptor clusters. Proc Natl Acad Sci USA 107: 10860-5.
40. Bocharov EV, Mayzel ML, Volynsky PE, Goncharuk MV, et al. 2008. Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase Eph A1. J Biol Chem 283: 29385-95.
41. Bocharov EV, Mayzel ML, Volynsky PE, Mineev KS, et al. 2010. Left-handed dimer of EphA2 transmembrane domain: helix packing diversity among receptor tyrosine kinases. Biophys J 98: 881-9.
42. Dietz MS, Hasse D, Ferraris DM, Gohler A, et al. 2013. Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells. BMC Biophys 6: 6.
43. Sarabipour S, Hristova K. 2013. FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain. Biophys J 105: 165-71.
44. Liongue C, Ward AC. 2007. Evolution of Class I cytokine receptors. BMC Evol Biol 7: 120.
45. Langer JA, Cutrone EC, Kotenko S. 2004. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 15: 33-48.
46. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, et al. 1993. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74: 237-44.
47. Cunningham BC, Ultsch M, De Vos AM, Mulkerrin MG, et al. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254: 821-5.
48. Ross RJ, Leung KC, Maamra M, Bennett W, et al. 2001. Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin Endocrinol Metab 86: 1716-23.
49. Gent J, van Kerkhof P, Roza M, Bu G, et al. 2002. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99: 9858-63.
50. Constantinescu SN, Keren T, Socolovsky M, Nam H, et al. 2001. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA 98: 4379-84.
51. Livnah O, Stura EA, Middleton SA, Johnson DL, et al. 1999. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283: 987-90.
52. Gadd SL, Clevenger CV. 2006. Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. Mol Endocrinol 20: 2734-46.
53. Matthews EE, Thevenin D, Rogers JM, Gotow L, et al. 2011. Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation. FASEB J 25: 2234-44.
54. Peelman F, Zabeau L, Moharana K, Savvides SN, et al. 2014. 20 years of leptin: insights into signaling assemblies of the leptin receptor. J Endocrinol 223: T9-T23.
55. Nakashima K, Narazaki M, Taga T. 1997. Leptin receptor (OB-R) oligomerizes with itself but not with its closely related cytokine signal transducer gp130. FEBS Lett 403: 79-82.
56. Couturier C, Jockers R. 2003. Activation of the leptin receptor by a ligand-induced conformational change of constitutive receptor dimers. J Biol Chem 278: 26604-11.
57. Biener E, Charlier M, Ramanujan VK, Daniel N, et al. 2005. Quantitative FRET imaging of leptin receptor oligomerization kinetics in single cells. Biol Cell 97: 905-19.
58. Chua AO, Chizzonite R, Desai BB, Truitt TP, et al. 1994. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 153: 128-36.
59. Garbers C, Aparicio-Siegmund S, Rose-John S. 2015. The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition. Curr Opin Immunol 34: 75-82.
60. Schuster B, Meinert W, Rose-John S, Kallen KJ. 2003. The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane. FEBS Lett 538: 113-6.
61. Puimege L, Libert C, Van Hauwermeiren F. 2014. Regulation and dysregulation of tumor necrosis factor receptor-1. Cytokine Growth Factor Rev 25: 285-300.
62. Chan FK, Chun HJ, Zheng L, Siegel RM, et al. 2000. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288: 2351-4.
63. Latz E, Verma A, Visintin A, Gong M, et al. 2007. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8: 772-9.
64. Ogawa H, Qiu Y, Ogata CM, Misono KS. 2004. Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction. J Biol Chem 279: 28625-31.
65. Murayama T, Takayama J, Fujiwara M, Maruyama IN. 2013. Environmental alkalinity sensing mediated by the transmembrane guanylyl cyclase GCY-14 in C. elegans. Curr Biol 23: 1007-12.
66. Cobret L, De Tauzia ML, Ferent J, Traiffort E, et al. 2015. Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signaling. Br J Pharmacol 172: 841-56.
67. Milligan DL, Koshland DE, Jr. 1988. Site-directed cross-linking. Establishing the dimeric structure of the aspartate receptor of bacterial chemotaxis. J Biol Chem 263: 6268-75.
68. Lin LN, Li J, Brandts JF, Weis RM. 1994. The serine receptor of bacterial chemotaxis exhibits half-site saturation for serine binding. Biochemistry 33: 6564-70.
69. Khorchid A, Inouye M, Ikura M. 2005. Structural characterization of Escherichia coli sensor histidine kinase EnvZ: the periplasmic C-terminal core domain is critical for homodimerization. Biochem J 385: 255-64.
70. Riedel H, Dull TJ, Schlessinger J, Ullrich A. 1986. A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor. Nature 324: 68-70.
71. Riedel H, Dull TJ, Honegger AM, Schlessinger J, et al. 1989. Cytoplasmic domains determine signal specificity, cellular routing characteristics and influence ligand binding of epidermal growth factor and insulin receptors. EMBO J 8: 2943-54.
72. Ballotti R, Lammers R, Scimeca JC, Dull T, et al. 1989. Intermolecular transphosphorylation between insulin receptors and EGF-insulin receptor chimera. EMBO J 8: 3303-9.
73. Moe GR, Bollag GE, Koshland DE, Jr. 1989. Transmembrane signaling by a chimera of the Escherichia coli aspartate receptor and the human insulin receptor. Proc Natl Acad Sci USA 86: 5683-7.
74. Maruyama IN, Mikawa YG, Maruyama HI. 1995. A model for transmembrane signalling by the aspartate receptor based on random-cassette mutagenesis and site-directed disulfide cross-linking. J Mol Biol 253: 530-46.
75. Chervitz SA, Falke JJ. 1996. Molecular mechanism of transmembrane signaling by the aspartate receptor: a model. Proc Natl Acad Sci USA 93: 2545-50.
76. Ottemann KM, Xiao W, Shin YK, Koshland DE, Jr. 1999. A piston model for transmembrane signaling of the aspartate receptor. Science 285: 1751-4.
77. Milburn MV, Prive GG, Milligan DL, Scott WG, et al. 1991. Three-dimensional structures of the ligand-binding domain of the bacterial aspartate receptor with and without a ligand. Science 254: 1342-7.
78. Kim SH, Wang W, Kim KK. 2002. Dynamic and clustering model of bacterial chemotaxis receptors: structural basis for signaling and high sensitivity. Proc Natl Acad Sci USA 99: 11611-5.
79. Ferris HU, Zeth K, Hulko M, Dunin-Horkawicz S, et al. 2014. Axial helix rotation as a mechanism for signal regulation inferred from the crystallographic analysis of the E. coli serine chemoreceptor. J Struct Biol 186: 349-56.
80. Fleishman SJ, Schlessinger J, Ben-Tal N. 2002. A putative molecular-activation switch in the transmembrane domain of erb B2. Proc Natl Acad Sci USA 99: 15937-40.
81. McKern NM, Lawrence MC, Streltsov VA, Lou MZ, et al. 2006. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 443: 218-21.
82. Smith BJ, Huang K, Kong G, Chan SJ, et al. 2010. Structural resolution of a tandem hormone-binding element in the insulin receptor and its implications for design of peptide agonists. Proc Natl Acad Sci USA 107: 6771-6.
83. Menting JG, Whittaker J, Margetts MB, Whittaker LJ, et al. 2013. How insulin engages its primary binding site on the insulin receptor. Nature 493: 241-5.
84. Renteria ME, Gandhi NS, Vinuesa P, Helmerhorst E, et al. 2008. A comparative structural bioinformatics analysis of the insulin receptor family ectodomain based on phylogenetic information. PLoS One 3: e3667.
85. Whitten AE, Smith BJ, Menting JG, Margetts MB, et al. 2009. Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change. J Mol Biol 394: 878-92.
86. Kavran JM, McCabe JM, Byrne PO, Connacher MK, et al. 2014. How IGF-1 activates its receptor. eLife 3: e03772.
87. Moscatello DK, Montgomery RB, Sundareshan P, McDanel H, et al. 1996. Transformational and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene 13: 85-96.
88. Munshi S, Kornienko M, Hall DL, Reid JC, et al. 2002. Crystal structure of the Apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity. J Biol Chem 277: 38797-802.
89. Lee J, Miyazaki M, Romeo GR, Shoelson SE. 2014. Insulin receptor activation with transmembrane domain ligands. J Biol Chem 289: 19769-77.
90. Remy I, Wilson IA, Michnick SW. 1999. Erythropoietin receptor activation by a ligand-induced conformation change. Science 283: 990-3.
91. Lu X, Gross AW, Lodish HF. 2006. Active conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J Biol Chem 281: 7002-11.
92. Seubert N, Royer Y, Staerk J, Kubatzky KF, et al. 2003. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. Mol Cell 12: 1239-50.
93. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, et al. 2005. Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12: 814-21.
94. Brooks AJ, Wooh JW, Tunny KA, Waters MJ. 2008. Growth hormone receptor; mechanism of action. Int J Biochem Cell Biol 40: 1984-9.
95. Poger D, Mark AE. 2010. Turning the growth hormone receptor on: evidence that hormone binding induces subunit rotation. Proteins 78: 1163-74.
96. Parat M, Blanchet J, De Lean A. 2010. Role of juxtamembrane and transmembrane domains in the mechanism of natriuretic peptide receptor A activation. Biochemistry 49: 4601-10.
97. Sharonov GV, Bocharov EV, Kolosov PM, Astapova MV, et al. 2014. Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase. J Biol Chem 289: 14955-64.
98. Chavent M, Chetwynd AP, Stansfeld PJ, Sansom MS. 2014. Dimerization of the EphA1 receptor tyrosine kinase transmembrane domain: insights into the mechanism of receptor activation. Biochemistry 53: 6641-52.
99. Manni S, Mineev KS, Usmanova D, Lyukmanova EN, et al. 2014. Structural and functional characterization of alternative transmembrane domain conformations in VEGF receptor 2 activation. Structure 22: 1077-89.
100. Brooks AJ, Dai W, O'Mara ML, Abankwa D, et al. 2014. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science 344: 1249783.
101. Endres NF, Das R, Smith AW, Arkhipov A, et al. 2013. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152: 543-56.
102. Harapin J, Eibauer M, Medalia O. 2013. Structural analysis of supramolecular assemblies by cryo-electron tomography. Structure 21: 1522-30.